Congress grumbles US trade official over Covid-19 intellectual property waiver


OOnce again, another week of work will soon come to an end. If you’re surprised that Friday has already arrived, maybe you’re working too hard? Either way, join us as we daydream about the weekend plans. Our schedule is uncertain at this time, but we do plan to hang out with a few short people, walk around with the official mascots, and take a few naps. And you? It’s a great time of year to enjoy the great outdoors. You could walk around the garden. Or find that special someone after months of keeping your distance. Well whatever you do have a good time. But be careful. Enjoy it and see you soon. …

U.S. Trade Representative Katherine Tai again received comment on Thursday from lawmakers opposing the Biden administration’s call to waive intellectual property protection on Covid-19 vaccines, Law360 Reports. Tai, who testified before the House Ways and Means Committee, was pressed to get details of what the United States would look for in the waiver negotiations, how long it would last, how it would be implemented. work and whether the United States would pull out if other countries insisted it applied to more than just vaccines.

Unlock this article by subscribing to STAT + and enjoy your first 30 days free!


What is that?

STAT + is STAT’s premium subscription service for in-depth coverage and analysis in biotechnology, pharmacy, policy and life sciences. Our award-winning team covers the news on Wall Street, political developments in Washington, early scientific breakthroughs and clinical trial results, and the disruption of healthcare in Silicon Valley and beyond.

What is included?

  • Daily reports and analyzes
  • The most comprehensive coverage in the industry by a team of powerful journalists
  • Subscriber newsletters
  • Daily newsletters to keep you informed about the most important news in the sector
  • STAT + conversations
  • Weekly opportunities to engage with our journalists and leading industry experts in live video chats
  • Exclusive industry events
  • Premium access to subscriber-only networking events nationwide
  • The best reporters in the industry
  • The most trusted and connected newsroom in the healthcare industry
  • And much more
  • Exclusive interviews with industry leaders, profiles and high-end tools, like our CRISPR Trackr.

Source link

Leave A Reply

Your email address will not be published.